Ensysce Biosciences (ENSC) Accumulated Expenses (2017 - 2021)

Ensysce Biosciences (ENSC) has reported Accumulated Expenses for 4 consecutive years, with $411941.0 the latest figure, recorded in Q2 2021.

• In Q2 2021, Accumulated Expenses changed N/A year-over-year to $411941.0; the TTM figure through Jun 2021 stood at $411941.0 (changed N/A YoY), while the FY2020 annual figure was $344792.0, changed N/A from the prior year.
• Accumulated Expenses improved to $411941.0 in Q2 2021 per ENSC's latest filing, from $344792.0 in the prior quarter.
• Across five years, Accumulated Expenses topped out at $411941.0 in Q2 2021 and bottomed at $8640.0 in Q1 2018.
• Historically, Accumulated Expenses has averaged $118847.6 across 4 years, with a median of $8640.0 in 2018.
• On a YoY basis, Accumulated Expenses climbed as much as 78.74% in 2018 and fell as far as 78.74% in 2018.
• Ensysce Biosciences' Accumulated Expenses stood at $40640.0 in 2017, then slumped by 78.74% to $8640.0 in 2018, then soared by 3890.65% to $344792.0 in 2020, then rose by 19.48% to $411941.0 in 2021.
• Business Quant data shows ENSC's Accumulated Expenses at $411941.0 in Q2 2021, $344792.0 in Q4 2020, and $8640.0 in Q4 2018.